Sleep Disorders Trial, Recruiting NCT06411561 Sponsor: University of Washington Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06411561
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 60 years of age or older
  • People who are currently admitted to University of Washington Medical Center or Harborview Medical Center
  • People who have spent more than 24 hours in an intensive care unit (ICU)
  • People who have recovered from critical care and moved to a general hospital ward, or who have been discharged from the ICU
  • People who speak English or Spanish fluently
  • People who were able to independently manage everyday tasks such as bathing, dressing, and eating before their hospital stay (confirm with trial site)

Who may not be able to join:

  • People with a known or suspected diagnosis of Alzheimer's disease or dementia, or who are currently prescribed medication for dementia
  • People with a documented history of bipolar disorder or schizophrenia
  • People who have had a recent stroke or traumatic brain injury
  • People with severe vision impairment
  • People with severe hearing impairment
  • People with severe paralysis or significant weakness in their dominant arm
  • People who were transferred to the hospital from a skilled nursing facility or inpatient rehabilitation centre

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Maya N Elias, PhD, MA, RN, University of Washington

Phone: 206-543-8564

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 December 2024
Est. completion
31 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cognitive function; Cognitive function; Cognitive function; Cognitive function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov